Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Titel:
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Auteur:
Fizazi, Karim Scher, Howard I Molina, Arturo Logothetis, Christopher J Chi, Kim N Jones, Robert J Staffurth, John N North, Scott Vogelzang, Nicholas J Saad, Fred Mainwaring, Paul Harland, Stephen Goodman Jr, Oscar B Sternberg, Cora N Li, Jin Hui Kheoh, Thian Haqq, Christopher M de Bono, Johann S